Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.

We haven't written up this one. CNBC has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at cnbc.com →

More in Finance & Markets

More from Sunday 2 August →